The diagnosis of VITT is confirmed if antibodies against PF4 are detectable in patients with an acute thrombotic event and concomitant thrombocytopenia, and prior COVID-19 vaccination with an adenovirus vector vaccine in an appropriate time window [63]. Here, PF4 is linked to COVID-19.